N. Anthony Coles - 17 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
By: Beverly Dubs as attorney-in-fact For: N. Anthony Coles
Issuer symbol
REGN
Transactions as of
17 Aug 2021
Net transactions value
-$1,827,180
Form type
4
Filing time
19 Aug 2021, 16:04:04 UTC
Previous filing
16 Aug 2021
Next filing
17 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $310,923 +900 +100% $345.47 1,802 17 Aug 2021 Direct F1
transaction REGN Common Stock Sale $585,000 -900 -50% $650.00 902 17 Aug 2021 Direct F1
transaction REGN Common Stock Options Exercise $1,761,897 +5,100 +565% $345.47 6,002 18 Aug 2021 Direct F1
transaction REGN Common Stock Sale $3,315,000 -5,100 -85% $650.00 902 18 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -900 -8.2% $0.000000 10,139 17 Aug 2021 Common Stock 900 $345.47 Direct F1, F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,100 -50% $0.000000 5,039 18 Aug 2021 Common Stock 5,100 $345.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.